BFEC
DGX icon

Benjamin F. Edwards & Company’s Quest Diagnostics DGX Stock Holding History

Benjamin F. Edwards & Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$15K Sell
111
-48
-30% -$6.57K ﹤0.01% 1601
2024
Q1 		$21K Sell
159
-10,738
-99% -$1.39M ﹤0.01% 1513
2023
Q4 		$1.5M Buy
10,897
+1,373
+14% +$181K 0.03% 398
2023
Q3 		$1.16M Buy
9,524
+710
+8% +$94.6K 0.04% 341
2023
Q2 		$1.24M Buy
8,814
+8,277
+1,541% +$1.14M 0.05% 328
2023
Q1 		$76K Sell
537
-101
-16% -$14.4K ﹤0.01% 988
2022
Q4 		$100K Buy
638
+336
+111% +$48.3K ﹤0.01% 899
2022
Q3 		$37K Sell
302
-488
-62% -$64.3K ﹤0.01% 1124
2022
Q2 		$105K Sell
790
-222
-22% -$30.3K 0.01% 846
2022
Q1 		$139K Buy
1,012
+57
+6% +$7.95K 0.01% 777
2021
Q4 		$165K Hold
955
– – 0.01% 744
2021
Q3 		$139K Buy
955
+23
+2% +$3.37K 0.01% 776
2021
Q2 		$123K Sell
932
-88
-9% -$11.5K 0.01% 786
2021
Q1 		$131K Sell
1,020
-89
-8% -$11K 0.01% 775
2020
Q4 		$132K Buy
1,109
+318
+40% +$38.8K 0.01% 741
2020
Q3 		$91K Buy
791
+623
+371% +$73.6K 0.01% 765
2020
Q2 		$19K Buy
168
+27
+19% +$2.86K ﹤0.01% 1140
2020
Q1 		$11K Sell
141
-788
-85% -$81.6K ﹤0.01% 1220
2019
Q4 		$99K Buy
929
+788
+559% +$82.2K 0.01% 783
2019
Q3 		$15K Sell
141
-434
-75% -$44.6K ﹤0.01% 1277
2019
Q2 		$59K Buy
575
+79
+16% +$7.59K ﹤0.01% 856
2019
Q1 		$45K Sell
496
-48
-9% -$4.16K ﹤0.01% 894
2018
Q4 		$45K Buy
544
+134
+33% +$12.6K ﹤0.01% 856
2018
Q3 		$44K Hold
410
– – ﹤0.01% 902
2018
Q2 		$45K Hold
410
– – ﹤0.01% 876
2018
Q1 		$41K Hold
410
– – ﹤0.01% 892
2017
Q4 		$40K Hold
410
– – ﹤0.01% 854
2017
Q3 		$38K Buy
410
+355
+645% +$37.7K ﹤0.01% 831
2017
Q2 		$6K Hold
55
– – ﹤0.01% 1199
2017
Q1 		$5K Buy
+55
New +$5.24K ﹤0.01% 1153

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Benjamin F. Edwards & Company's DGX Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Quest Diagnostics (DGX) stake by 30% in Q2 2024, selling an estimated $6.57K and leaving 111 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

Benjamin F. Edwards & Company first reported a position in DGX in Q1 2017 and has held it in 30 quarters since. The position peaked at $1.5M in Q4 2023. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

  • Benjamin F. Edwards & Company held 111 shares of Quest Diagnostics worth $15K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 48 Quest Diagnostics shares in Q2 2024, an estimated $6.57K.
  • Quest Diagnostics made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1601 holding.
  • Benjamin F. Edwards & Company first reported a position in Quest Diagnostics in Q1 2017 and has held it in 30 quarters since.
  • Benjamin F. Edwards & Company's Quest Diagnostics position peaked at $1.5M in Q4 2023.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.